Hologic to Develop Analyte Specific Reagents for H5N1 Bird Flu
Hologic, Inc. has partnered with the CDC to develop analyte specific reagents (ASRs) to detect H5N1 bird flu.
Read MorePosted by Chris Wolski | Dec 19, 2024 | Molecular Diagnostics |
Hologic, Inc. has partnered with the CDC to develop analyte specific reagents (ASRs) to detect H5N1 bird flu.
Read MorePosted by Andy Lundin | Dec 17, 2024 | Point-of-Care |
A new nanobody-based immunosensor is capable of stable operation in undiluted biological fluids with promising applications in POC testing.
Read MorePosted by Andy Lundin | Dec 17, 2024 | Emerging & Zoonotic Diseases, Point-of-Care |
Labcorp introduced a molecular H5 bird flu test to help diagnose human infections with the H5N1 virus, enhancing public health response.
Read MorePosted by Andy Lundin | Dec 13, 2024 | Tuberculosis |
WHO granted prequalification to a tuberculosis molecular diagnostic test that delivers rapid detection of TB and drug resistance.
Read MorePosted by Andy Lundin | Dec 11, 2024 | Diagnostic Technologies |
Researchers developed an optimized pooled testing framework, enabling faster, cost-effective, and accurate infectious disease screening.
Read More